RADAY GILEAD enters REDHILL BIOPHARMA LTD. with 307.58M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Ordinary Shares
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 307.58M | Direct |
| Total | 307.58M | 307.58M direct |
Stock Option (Right to Buy)
DirectUnderlying shares
600K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
400K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
250K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
180K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
American Depositary Shares
DirectUnderlying shares
45.37M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
570K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Underlying
47.37M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares | — | — | 600K | N/A | |
| Stock Option (Right to Buy) Direct | Ordinary Shares | — | — | 400K | N/A | |
| Stock Option (Right to Buy) Direct | Ordinary Shares | — | — | 250K | N/A | |
| Stock Option (Right to Buy) Direct | Ordinary Shares | — | — | 180K | N/A | |
| American Depositary Shares Direct | Ordinary Shares | — | — | 45.37M | N/A | |
| Stock Option (Right to Buy) Direct | Ordinary Shares | — | — | 570K | N/A | |
| Total | 47.37M | 0.00 | ||||